Summary
- Current Price
- As of today, BTAI price is $1.37, down -4.20% on
- Current Price All-Time High
- BTAI price is currently -99.88% below its historical high of $1,144.00 set on
- Market Cap
- BTAI current market cap is $30M, up +150.52% over the past 365 days
- PE Ratio
- BTAI PE ratio is unknown
- Revenue
- BTAI current annual revenue is $2.27M, up +64.20% year-over-year
- Next Earnings
- The next earnings release for BTAI is on
Profile
| Metric | Value |
|---|---|
| Full Name | BioXcel Therapeutics, Inc. |
| Ticker | NASDAQ: BTAI |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | bioxceltherapeutics.com |
| Employees | 37 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $1.37 | ||
| Price, 1D Change | -4.20% | |
| $30M | ||
| - | ||
| - | ||
| 2.19 | ||
| $2M | ||
| Revenue, 1Y Change | +64.20% | |
| -$23.51 | ||
| EPS, 1Y Change | -282.48% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | N/A | |
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:16 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$23.51 | ||
| EPS Estimate | -$6.51 | |
| EPS Est. Change | +72.33% | |
| $2.27M | ||
| Revenue Estimate | $544.52K | |
| Revenue Est. Change | -75.97% | |
| $1.37 | ||
| Price Target | - | $9.00 |
| Price Tgt. Change | - | +556.93% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$5.99 | -$6.15 | -2.62% | |
| -$25.33 | -$23.51 | +7.17% | |
| -$6.51 | N/A | +72.33% | |
| -$2.63 | N/A | +88.81% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $1.69M | $1.38M | -18.34% | |
| $2.84M | $2.27M | -20.32% | |
| $544.52K | N/A | -75.97% | |
| $1.52M | N/A | -33.01% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| -37.16% | ||
| -99.53% | ||
| +150.52% | ||
| -94.36% | ||
| +64.20% | ||
| +100.00% | ||
| -282.48% | ||
| -479.85% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $1.37 | ||
| $2.28 | ||
| SMA 200 vs Price | +66.14% | |
| $1.63 | ||
| SMA 50 vs Price | +18.70% | |
| 2.19 | ||
| $0.13 | ||
| 38.64 | ||
| 85.43% | ||
| 146.20% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $2.27M | ||
| -$23.51 | ||
| -$186.00K | ||
| -8.21% | ||
| -$63.47M | ||
| -2,801.15% | ||
| -$59.60M | ||
| -2,630.14% | ||
| -$63.17M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| -1.11 | ||
| 1.68 | ||
| 1.65 | ||
| - | ||
| 3 | ||
| -28.54 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 39.84 | ||
| -0.34 | ||
| -2.07 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| -$93.10M | ||
| $29.85M | ||
| $38.34M | ||
| $37.39M | ||
| $131.44M | ||
| $22.23M | ||
| $102.95M | ||
| $374.00K | ||
| $15.99M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $61.87M | ||
| $63.29M | ||
| $2.45M | ||
| $34.49M | ||
| $309.00K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$72.03M | ||
| $0.00 | ||
| $36.66M | ||
| $0.00 | ||
| -$72.03M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Rodman & Renshaw | ||
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| Mizuho | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| LUCID CAPITAL MARKETS | → | |
| HC Wainwright & Co. | → | |
| Rodman & Renshaw |
Analyst sentiment
Institutional ownership
Screeners with BTAI
FAQ
What is the ticker symbol for BioXcel Therapeutics, Inc.?
The ticker symbol for BioXcel Therapeutics, Inc. is NASDAQ:BTAI
Does BioXcel Therapeutics, Inc. pay dividends?
No, BioXcel Therapeutics, Inc. does not pay dividends
What sector is BioXcel Therapeutics, Inc. in?
BioXcel Therapeutics, Inc. is in the Healthcare sector
What industry is BioXcel Therapeutics, Inc. in?
BioXcel Therapeutics, Inc. is in the Biotechnology industry
What country is BioXcel Therapeutics, Inc. based in?
BioXcel Therapeutics, Inc. is headquartered in United States
When did BioXcel Therapeutics, Inc. go public?
BioXcel Therapeutics, Inc. initial public offering (IPO) was on March 8, 2018
Is BioXcel Therapeutics, Inc. in the S&P 500?
No, BioXcel Therapeutics, Inc. is not included in the S&P 500 index
Is BioXcel Therapeutics, Inc. in the NASDAQ 100?
No, BioXcel Therapeutics, Inc. is not included in the NASDAQ 100 index
Is BioXcel Therapeutics, Inc. in the Dow Jones?
No, BioXcel Therapeutics, Inc. is not included in the Dow Jones index
When was BioXcel Therapeutics, Inc. last earnings report?
BioXcel Therapeutics, Inc.'s most recent earnings report was on November 12, 2025
When does BioXcel Therapeutics, Inc. report earnings?
The next expected earnings date for BioXcel Therapeutics, Inc. is March 26, 2026
Data Sources & References
- BTAI Official Website www.bioxceltherapeutics.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1720893/000110465925109880/0001104659-25-109880-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1720893/000155837025003985/0001558370-25-003985-index.htm
- BTAI Profile on Yahoo Finance finance.yahoo.com/quote/BTAI
- BTAI Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/btai